Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/13/2025

Liver Dysfunction and Thrombocytopenia

Clinical Significance and Prevalence

  • Transfused platelets demonstrate shortened half-life of approximately 2.5-4.5 days in cirrhotic patients 1, 2
  • Low platelet counts in cirrhosis primarily reflect disease severity and portal hypertension rather than actual bleeding risk 3, 2

Critical Clinical Considerations

  • The American Association for the Study of Liver Diseases notes that standard coagulation tests do not accurately predict bleeding complications in cirrhotic patients because cirrhosis creates a "rebalanced" hemostatic state where both procoagulant and anticoagulant factors are reduced 2, 3